Addicted to proteostasis: How KRAS-driven cancers acquire resistance to clinical KRAS inhibitors is a research paper published in Cell chemical biology (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of General Medical Sciences
Grant: 1R01GM144617-01
National Institute of General Medical Sciences
Grant: T32GM008061
American Cancer Society
Grant: RSG-22-086-01-TBE
NIGMS NIH HHS
Grant: R01 GM144617
National Institutes of Health
FWCI
0.09
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals